Loading
MAIA Labs is a Czech company whose software watches the camera feed during a colonoscopy and flags possible polyps, the growths that can turn into bowel cancer. It also writes up the report automatically.
MAIA Labs s.r.o. is a Brno, Czech Republic, company founded in 2022, according to the company, that develops artificial intelligence for endoscopy. Its ColoMAIA II system plugs into the endoscopy tower to give real-time computer-aided detection (CADe) of polyps with visual and sound alerts, and automates the rest of the procedure record: worklist, recording, withdrawal timing, Boston Bowel Preparation Scale, lesion size estimates, Paris classification suggestions, voice notes and a structured report exported to hospital systems. The company reports CE marking under the EU Medical Device Regulation in 2026, an installation at Mayo Clinic Florida in 2026, and an FDA clearance process under way. Its first registered cancer trial, NCT07563816, a randomised multicentre investigation in Czechia comparing colonoscopy with and without ColoMAIA II assistance in adults aged 40 to 80, with the proportion of patients with at least one adenoma found as the main measure, was posted on ClinicalTrials.gov in May 2026 and is listed as completed.
Shares AI polyp detection in colonoscopy, Colorectal cancer.
Shares AI polyp detection in colonoscopy, Colorectal cancer.
Shares AI polyp detection in colonoscopy, Colorectal cancer.
Shares AI polyp detection in colonoscopy, Colorectal cancer.
Shares AI polyp detection in colonoscopy, Colorectal cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/